Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-26

Clinical Trial Update: Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial investigated ferumoxytol-enhanced MRI for imaging osteonecrosis and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Feraheme (ferumoxytol)

Snippet

Sponsor: Stanford University | Conditions: Osteonecrosis | Phase 4 | Status: COMPLETED | Results posted: 2024-11-26